MiR-4269, modulating ZEB1/OTX1 axis, exerts tumor inhibitory effects on pancreatic cancer progression and offers a new insight into the clinical treatment of pancreatic cancer patients [149]. This evidence concerns the gene OTX1 and neoplasm.